BR
Bruker
BRKR·NASDAQBillerica MAFounded 19609,000 employees
Large CapbiotechPublicOncology
Platform: MS NMR Instruments
Market Cap
$10B
All Drugs
5
Clinical Trials
11
Failed / Terminated
3
FDA Approved
1
Stock Price & Catalysts (BRKR)
Loading BRKR stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| BRK-7538 | BRK-7538 | Phase 2/3 | 2 | DLL3 | Endometrial CaCholangiocarcinoma | ||
| BRK-5301 | BRK-5301 | Preclinical | 1 | PCSK9 | Cholangiocarcinoma | ||
| BRK-4512 | BRK-4512 | Preclinical | 2 | GIP-R | MGPAH | ||
| Doxacilimab | BRK-4384 | NDA/BLA | 2 | HER2 | CholangiocarcinomaHCC | ||
| BRK-679 | BRK-679 | Approved | 4 | PRMT5 | Endometrial CaSCLC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (11)